Is Measles IgG Testing for Healthcare Providers Cost-Effective? Results From Seroprevalence Studies of Healthcare Providers in a Tertiary Public Hospital With a Large Foreign-Born Workforce.
1Department of Medicine,National University of Singapore,Singapore.
Aidan Lyanzhiang
AL
Tan
2Saw Swee Hock School of Public Health,National University of Singapore,Singapore.
Joanne
J
Yoong
3Department of Medicine,National University of Singapore,Singapore.
Jareena
J
Kasim
3Department of Medicine,National University of Singapore,Singapore.
Grant
G
Ciccone
2Saw Swee Hock School of Public Health,National University of Singapore,Singapore.
Judy Gek Khim
JG
Sng
1Department of Medicine,National University of Singapore,Singapore.
Paul A
PA
Tambyah
D000046:Academic Medical Centers; D003362:Cost-Benefit Analysis; D003428:Cross Infection / Q000453:epidemiology* / Q000821:virology*; D004196:Disease Outbreaks; D054242:Emigrants and Immigrants; D006282:Health Personnel; D006779:Hospitals, Public; D006801:Humans; D007074:Immunoglobulin G; D008457:Measles / Q000097:blood / Q000191:economics / Q000453:epidemiology* / Q000517:prevention & control; D008458:Measles Vaccine / Q000008:administration & dosage / Q000191:economics; D008459:Measles virus / Q000276:immunology; D016133:Polymerase Chain Reaction; D016036:Seroepidemiologic Studies; D012846:Singapore / Q000453:epidemiology
D007074:Immunoglobulin G; D008458:Measles Vaccine